Canwell Biotech Ltd.
PrivateLast Round
Series A
Extension
Aug 1, 2022
Total Funding Raised
$46.2M
Company Overview
Canwell Biotech Ltd. operates in Healthcare & Life Sciences and is based in Guangzhou. Its latest recorded funding round was a Series A Extension round in August 2022.
Canwell Biotech Ltd. is a biotechnology company that focuses on the research, development, and commercialization of innovative anti-tumor immunotherapies, including antibody-drug conjugates (ADCs) and cancer vaccines.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Canwell Biotech Ltd. Comparables
Compare Canwell Biotech Ltd. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Callio Therapeutics | 87% | |
| Eli Lilly and Company | 83% | |
| Coherent Biopharma | 82% |
For institutional investors. Book with your work email.
Canwell Biotech Ltd. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A Extension | Aug 1, 2022 | ||||
| Series A | Mar 18, 2022 | ||||
| Early Funding | Dec 1, 2020 |
For institutional investors. Book with your work email.
Canwell Biotech Ltd. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| China Capital Management Co., Ltd. | Series A |
| China Science and Technology Industry Investment Management | Series A, Early Funding |
| SDIC Venture Capital | Series A Extension |
| Jiuyo Capital Management | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Dec 1, 2020
Raised capital from 国科投资.
For institutional investors. Book with your work email.
Canwell Biotech Ltd. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Canwell Biotech Ltd.'s valuation, stock price, and market status.
Is Canwell Biotech Ltd. a public or private company?
Canwell Biotech Ltd. is a private company.
What is the current stock price of Canwell Biotech Ltd.?
Canwell Biotech Ltd. is a private company, so its shares have no public market price. Caplight tracks Canwell Biotech Ltd.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Canwell Biotech Ltd. worth (valuation)?
Valuation information for Canwell Biotech Ltd. is not publicly available.
Can I buy Canwell Biotech Ltd. stock?
Canwell Biotech Ltd. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Canwell Biotech Ltd.'s last funding round?
Canwell Biotech Ltd.'s most recent funding round was Series A Extension on August 1, 2022.
Who are the main investors in Canwell Biotech Ltd.?
Key investors in Canwell Biotech Ltd. include SDIC Venture Capital.
Will Canwell Biotech Ltd. IPO soon?
No public IPO plans have been announced for Canwell Biotech Ltd..
How can I track Canwell Biotech Ltd. secondary market activity?
Caplight tracks bids, offers, and trades in Canwell Biotech Ltd.'s shares on secondary markets.